about
Early postoperative hyperglycaemia is not a risk factor for infectious complications and prolonged in-hospital stay in patients undergoing oesophagectomy: a retrospective analysis of a prospective trialThe effect of diabetes on mortality in critically ill patients: a systematic review and meta-analysisPrevalence of diabetes mellitus and the performance of a risk score among Hindustani Surinamese, African Surinamese and ethnic Dutch: a cross-sectional population-based study.The angiotensin converting enzyme insertion/deletion polymorphism and differences in fasting plasma glucose in Hindustani Surinamese, African Surinamese and ethnic Dutch: the population-based SUNSET-study.Rationale, design, and baseline data of the insulin glargine (Lantus) versus insulin detemir (Levemir) Treat-To-Target (L2T3) study: A multinational, randomized noninferiority trial of basal insulin initiation in type 2 diabetes.The Diabetes Pearl: Diabetes biobanking in The NetherlandsDiabetes patients' experiences with the implementation of insulin therapy and their perceptions of computer-assisted self-management systems for insulin therapyIntensive lifestyle intervention in general practice to prevent type 2 diabetes among 18 to 60-year-old South Asians: 1-year effects on the weight status and metabolic profile of participants in a randomized controlled trial.Ethnic differences in weight loss and diabetes remission after bariatric surgery: a meta-analysis.Screening South Asians for type 2 diabetes and prediabetes: (1) comparing oral glucose tolerance and haemoglobin A1c test results and (2) comparing the two sets of metabolic profiles of individuals diagnosed with these two tests.Glucose variability; does it matter?The metabolic syndrome in adults prenatally exposed to the Dutch famine.(18)F-fluorodeoxyglucose uptake in brown adipose tissue during insulin-induced hypoglycemia and mild cold exposure in non-diabetic adults.A 24-week, randomized, treat-to-target trial comparing initiation of insulin glargine once-daily with insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs.Insulin lispro.Efficacy and safety of two 5 day insulin dosing regimens to achieve strict glycaemic control in patients with acute ischaemic stroke.Safety and usability evaluation of a web-based insulin self-titration system for patients with type 2 diabetes mellitus.Additional lunchtime basal insulin during insulin lispro intensive therapy in a randomized, multicenter, crossover study in adults : a real-life design.Combining 123I-metaiodobenzylguanidine SPECT/CT and 18F-FDG PET/CT for the assessment of brown adipose tissue activity in humans during cold exposure.[Blood glucose quickly under control in diabetes mellitus 2].Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo.Fasting and postprandial activity of brown adipose tissue in healthy men.The Fallacy of Hindsight: Response to Moses and KoenenIntensive insulin therapy in patients with type 2 diabetesCompatibility of insulin pens and cartridgesNice insulins, pity about the evidenceEndothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetesRe: trial comparing insulin detemir with insulin glargineThe glycocalyx and cardiovascular disease in diabetes: should we judge the endothelium by its cover?Formative usability evaluation of a web-based insulin self-titration system: preliminary results[SGLT-2 inhibitors: diabetes treatment by glycosuria; literature review on the effect of dapagliflozin]
P50
Q24801340-31BC51B9-64D5-49B3-80F0-56C07106DA40Q27028133-3378B55E-37F7-4FD6-B0F1-1C1ACA7312F7Q29353913-979192E1-40F8-4E5A-BA3B-FB4A187C6232Q29353924-84891FFF-0BFC-40F2-81AE-152022FF0E60Q33515774-3F9F0B99-9D28-45B9-9B0A-5EB1FCB36D61Q34468293-C7392B37-BB3D-43E9-B39D-793EB6A3240DQ34657801-010B6C55-2853-4A53-B948-FEF77AA3D3BEQ34872880-825F726A-857D-4318-9B82-1F67E140E844Q36181356-1F2C652A-1F09-4C2A-A018-91188CDB3FF2Q36980895-7357E869-978D-48C3-87E5-6C1D1061071CQ37645704-6666F3ED-BAD2-4DD0-95A3-4543025EF234Q38460240-AE0A1A84-8168-449F-BDE0-643D3074936BQ39145919-053EB74C-4605-431B-B4D4-16461B410BE1Q40717578-F51D6BAD-A8F9-4CD4-B2E9-1237FAE380DAQ41528865-23C0776B-21A6-4576-A7E2-6C2385BA5C4FQ43291178-514A827B-99E0-4DEB-9B43-ED4BF36A9497Q43665124-FD8C9518-822B-4B5B-BCD9-B607BFA4537DQ43937028-7F277640-1233-4AE8-89D5-614B5FD47AD4Q45730866-E3F22C8A-9350-43E3-926C-8178C6D57552Q46060404-B01100A7-49F2-4DDD-B1B7-884AEA4B0912Q46917089-89E3E4D4-1D67-4783-B8EB-5215663DBFD9Q51353231-0E2CD215-762C-49ED-B511-FC6DE0C7DAC9Q58886188-9B54CA15-CD94-4CF0-8726-A599B0F03C8BQ58886203-A491FAE8-F61F-4B4D-BFC1-AB36751F8430Q73930964-F8DE967C-B77A-4245-9498-268A2677C493Q80625647-FAEBACFC-8D91-4451-98F4-74C6A5F926A2Q82984599-708016B1-5BFD-4A1F-A5D0-CE5CB494A503Q84088689-71083EB0-7AAA-4742-94B9-2BCDB08F87B6Q84258316-5D30113E-6B9C-4BEB-8A80-1A4590160C19Q84753632-7900A536-3509-4188-88B6-996C9F8B238BQ85953222-BB60D639-75EC-4847-A725-C621581FEDDC
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Frits Holleman
@ast
Frits Holleman
@en
Frits Holleman
@es
Frits Holleman
@nl
Frits Holleman
@sl
type
label
Frits Holleman
@ast
Frits Holleman
@en
Frits Holleman
@es
Frits Holleman
@nl
Frits Holleman
@sl
prefLabel
Frits Holleman
@ast
Frits Holleman
@en
Frits Holleman
@es
Frits Holleman
@nl
Frits Holleman
@sl
P106
P1153
6602805434
P21
P31
P496
0000-0001-5858-5089